cbd revenue – Illumination Brands

March 15, 2022

CBD Global Sciences Begins the Process for a Name Change

CBD Global Sciences, Inc. is pleased to announce that it has begun the process to formally change its name from “CBD Global Sciences” to “Global Sciences Inc.”, dropping CBD from its name. It has begun to operate under the trade name “Global Sciences” until full shareholder and regulatory approval of […]

December 31, 2021

CBD Global Sciences Announces Retirement of Over $9 Million in Outstanding Debt

CBD Global Sciences, Inc. is pleased to announce the completion of its previously announced (August 12, 2021) debt restructuring involving the retirement of over CDN$9 million in outstanding debt through the issuance of 8,908,876 Common Shares at an issue price of $0.1575 per share and 318,688 Series A preferred shares […]

December 16, 2021

CBD Global Sciences Reports Improving Q3 2021 Financial Results

CBD Global Sciences, Inc. is pleased to share their Q3 2021 results with highlighted details on the Company’s progress. The Company filed its Q3 financials and MD&A on November 29, 2021 to the regulators and the Canadian Securities Exchange. The financials submitted reflect some of the positive results of the […]

December 7, 2021

Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for Lil’ Baby’s Oowee Lemonade by RAP SNACKS®

CBD Global Sciences, Inc. is pleased to share that it is adding new brands to its growing distribution channel. Legacy Distribution Group is one of the country’s first CBD-focused Direct Store Delivery (DSD) distributors. Dedicated to providing “Best in Class” products to its retailers, we are focused on introducing both CBD and […]

October 18, 2021

CBD Global Sciences’ Purchase of Resinosa LLC, a Colorado CBD Processing and Manufacturing Company, Completed

CBD Global Sciences, Inc. is pleased to announce that on October 15, 2021, it closed its previously announced acquisition of 100% of Resinosa LLC, a CBD company located in Silver Cliff Colorado (the “Acquisition”). Resinosa has been in business in the CBD industry for over 6 years and is a […]

September 27, 2021

CBD Global Sciences Resumes Trading After Filing of Financials

CBD Global Sciences, Inc. is pleased to share the news that, following the filing of its 2020 annual, and Q1 2021 and Q2 2021 financial statements and MD&A, the previously issued cease trade order has been revoked and the Company’s common shares have been approved by the regulators and Canadian […]

August 12, 2021

CBD Global Sciences Debt Restructuring and Impact of both Global NV and Strasburg Pharms Bankruptcies, Post Bankruptcy Action Plans

CBD Global Sciences, Inc. is pleased to share detailed information about the debt restructuring of the company and the outcome of the two Chapter 7 bankruptcies. The landscape for CBD Global Sciences has changed dramatically since the emergence from the global pandemic and the completion of the two bankruptcies for […]

July 5, 2021

CBD Global Issues Fourth Bi-Weekly Status Report Regarding Management Cease Trade Order

CBD Global Sciences Inc. (CSE: CBDN) (the “Corporation“) further to its press releases dated May 14, 2021, May 28, 2021, and June 15, 2021, provides this fourth bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default […]

May 28, 2021

CBD Global Issues Second Bi-Weekly Status Report Regarding Management Cease Trade Order

CBD Global Sciences Inc. further to its press release dated May 14, 2021 provides this second bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default announcement of April 14, 2021 (the “Default Notice”), the Corporation announced […]

May 14, 2021

CBD Global Issues First Bi-Weekly Report Regarding Management Cease Trade Order

CBD Global Sciences Inc. provides this initial bi-weekly default status report in accordance with National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”). In the Corporation’s initial default announcement of April 14, 2021 (the “Default Notice”), the Corporation announced the delay in the filing of its audited annual […]

April 14, 2021

CBD Global Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order

CBD Global Sciences Inc. would like to provide an update on the status of the filing of its annual financial statements, accompanying management’s discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (collectively, the “Annual Filings“). Due to the continued impact of COVID-19, […]

April 1, 2021

Legacy Distribution Group, A Subsidiary of CBD Global Sciences, to Begin Distribution for Mad Tasty

CBD Global Sciences, Inc., is pleased to announce the addition of new brands to its CBD products distribution channel. Legacy Distribution Group is one of the country’s first CBD-only Direct Store Delivery (DSD) distributors. CBD Global’s Legacy Distribution Group recently welcomed Mad Tasty to its family of CBD brands. Legacy is […]

August 25, 2020

Global Sciences Reports 2019 Year End Results

CBD Global Sciences, Inc. today announced the release of financial and operational results for the fourth quarter ended December 31,2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All amounts are expressed in U.S. dollars. Financial Highlights For the twelve months ended December 31, 2019 […]